Cervical Cancer Diagnostic Market - Global Outlook and Forecast 2022-2028

March 2022 | 63 pages | ID: C0FDFFE63034EN
Market Monitor Global

Abstracts

Cervical cancer is a cancer arising from the cervix.

This report contains market size and forecasts of Cervical Cancer Diagnostic in Global, including the following market information:

Global Cervical Cancer Diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cervical Cancer Diagnostic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Pap Testing Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cervical Cancer Diagnostic include Cooper Surgical, Becton Dickinson, Hologic, Quest Diagnostics, QIAGEN, Guided Therapeutics, Siemens, OncoHealth and Arbor Vita, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cervical Cancer Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cervical Cancer Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cervical Cancer Diagnostic Market Segment Percentages, by Type, 2021 (%)

• Pap Testing
• HPV Testing
• Colposcopy
• Cervical Biopsies
• Cystoscopy

Global Cervical Cancer Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cervical Cancer Diagnostic Market Segment Percentages, by Application, 2021 (%)

• Cervical Cancer Treament
• Others

Global Cervical Cancer Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cervical Cancer Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cervical Cancer Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cervical Cancer Diagnostic revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Cooper Surgical
• Becton Dickinson
• Hologic
• Quest Diagnostics
• QIAGEN
• Guided Therapeutics
• Siemens
• OncoHealth
• Arbor Vita
• Zilico
• Beckman Coulter

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cervical Cancer Diagnostic Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cervical Cancer Diagnostic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CERVICAL CANCER DIAGNOSTIC OVERALL MARKET SIZE

2.1 Global Cervical Cancer Diagnostic Market Size: 2021 VS 2028
2.2 Global Cervical Cancer Diagnostic Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cervical Cancer Diagnostic Players in Global Market
3.2 Top Global Cervical Cancer Diagnostic Companies Ranked by Revenue
3.3 Global Cervical Cancer Diagnostic Revenue by Companies
3.4 Top 3 and Top 5 Cervical Cancer Diagnostic Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cervical Cancer Diagnostic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cervical Cancer Diagnostic Players in Global Market
  3.6.1 List of Global Tier 1 Cervical Cancer Diagnostic Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cervical Cancer Diagnostic Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Cervical Cancer Diagnostic Market Size Markets, 2021 & 2028
  4.1.2 Pap Testing
  4.1.3 HPV Testing
  4.1.4 Colposcopy
  4.1.5 Cervical Biopsies
  4.1.6 Cystoscopy
4.2 By Type - Global Cervical Cancer Diagnostic Revenue & Forecasts
  4.2.1 By Type - Global Cervical Cancer Diagnostic Revenue, 2017-2022
  4.2.2 By Type - Global Cervical Cancer Diagnostic Revenue, 2023-2028
  4.2.3 By Type - Global Cervical Cancer Diagnostic Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cervical Cancer Diagnostic Market Size, 2021 & 2028
  5.1.2 Cervical Cancer Treament
  5.1.3 Others
5.2 By Application - Global Cervical Cancer Diagnostic Revenue & Forecasts
  5.2.1 By Application - Global Cervical Cancer Diagnostic Revenue, 2017-2022
  5.2.2 By Application - Global Cervical Cancer Diagnostic Revenue, 2023-2028
  5.2.3 By Application - Global Cervical Cancer Diagnostic Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cervical Cancer Diagnostic Market Size, 2021 & 2028
6.2 By Region - Global Cervical Cancer Diagnostic Revenue & Forecasts
  6.2.1 By Region - Global Cervical Cancer Diagnostic Revenue, 2017-2022
  6.2.2 By Region - Global Cervical Cancer Diagnostic Revenue, 2023-2028
  6.2.3 By Region - Global Cervical Cancer Diagnostic Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Cervical Cancer Diagnostic Revenue, 2017-2028
  6.3.2 US Cervical Cancer Diagnostic Market Size, 2017-2028
  6.3.3 Canada Cervical Cancer Diagnostic Market Size, 2017-2028
  6.3.4 Mexico Cervical Cancer Diagnostic Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Cervical Cancer Diagnostic Revenue, 2017-2028
  6.4.2 Germany Cervical Cancer Diagnostic Market Size, 2017-2028
  6.4.3 France Cervical Cancer Diagnostic Market Size, 2017-2028
  6.4.4 U.K. Cervical Cancer Diagnostic Market Size, 2017-2028
  6.4.5 Italy Cervical Cancer Diagnostic Market Size, 2017-2028
  6.4.6 Russia Cervical Cancer Diagnostic Market Size, 2017-2028
  6.4.7 Nordic Countries Cervical Cancer Diagnostic Market Size, 2017-2028
  6.4.8 Benelux Cervical Cancer Diagnostic Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Cervical Cancer Diagnostic Revenue, 2017-2028
  6.5.2 China Cervical Cancer Diagnostic Market Size, 2017-2028
  6.5.3 Japan Cervical Cancer Diagnostic Market Size, 2017-2028
  6.5.4 South Korea Cervical Cancer Diagnostic Market Size, 2017-2028
  6.5.5 Southeast Asia Cervical Cancer Diagnostic Market Size, 2017-2028
  6.5.6 India Cervical Cancer Diagnostic Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Cervical Cancer Diagnostic Revenue, 2017-2028
  6.6.2 Brazil Cervical Cancer Diagnostic Market Size, 2017-2028
  6.6.3 Argentina Cervical Cancer Diagnostic Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cervical Cancer Diagnostic Revenue, 2017-2028
  6.7.2 Turkey Cervical Cancer Diagnostic Market Size, 2017-2028
  6.7.3 Israel Cervical Cancer Diagnostic Market Size, 2017-2028
  6.7.4 Saudi Arabia Cervical Cancer Diagnostic Market Size, 2017-2028
  6.7.5 UAE Cervical Cancer Diagnostic Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Cooper Surgical
  7.1.1 Cooper Surgical Corporate Summary
  7.1.2 Cooper Surgical Business Overview
  7.1.3 Cooper Surgical Cervical Cancer Diagnostic Major Product Offerings
  7.1.4 Cooper Surgical Cervical Cancer Diagnostic Revenue in Global Market (2017-2022)
  7.1.5 Cooper Surgical Key News
7.2 Becton Dickinson
  7.2.1 Becton Dickinson Corporate Summary
  7.2.2 Becton Dickinson Business Overview
  7.2.3 Becton Dickinson Cervical Cancer Diagnostic Major Product Offerings
  7.2.4 Becton Dickinson Cervical Cancer Diagnostic Revenue in Global Market (2017-2022)
  7.2.5 Becton Dickinson Key News
7.3 Hologic
  7.3.1 Hologic Corporate Summary
  7.3.2 Hologic Business Overview
  7.3.3 Hologic Cervical Cancer Diagnostic Major Product Offerings
  7.3.4 Hologic Cervical Cancer Diagnostic Revenue in Global Market (2017-2022)
  7.3.5 Hologic Key News
7.4 Quest Diagnostics
  7.4.1 Quest Diagnostics Corporate Summary
  7.4.2 Quest Diagnostics Business Overview
  7.4.3 Quest Diagnostics Cervical Cancer Diagnostic Major Product Offerings
  7.4.4 Quest Diagnostics Cervical Cancer Diagnostic Revenue in Global Market (2017-2022)
  7.4.5 Quest Diagnostics Key News
7.5 QIAGEN
  7.5.1 QIAGEN Corporate Summary
  7.5.2 QIAGEN Business Overview
  7.5.3 QIAGEN Cervical Cancer Diagnostic Major Product Offerings
  7.5.4 QIAGEN Cervical Cancer Diagnostic Revenue in Global Market (2017-2022)
  7.5.5 QIAGEN Key News
7.6 Guided Therapeutics
  7.6.1 Guided Therapeutics Corporate Summary
  7.6.2 Guided Therapeutics Business Overview
  7.6.3 Guided Therapeutics Cervical Cancer Diagnostic Major Product Offerings
  7.6.4 Guided Therapeutics Cervical Cancer Diagnostic Revenue in Global Market (2017-2022)
  7.6.5 Guided Therapeutics Key News
7.7 Siemens
  7.7.1 Siemens Corporate Summary
  7.7.2 Siemens Business Overview
  7.7.3 Siemens Cervical Cancer Diagnostic Major Product Offerings
  7.7.4 Siemens Cervical Cancer Diagnostic Revenue in Global Market (2017-2022)
  7.7.5 Siemens Key News
7.8 OncoHealth
  7.8.1 OncoHealth Corporate Summary
  7.8.2 OncoHealth Business Overview
  7.8.3 OncoHealth Cervical Cancer Diagnostic Major Product Offerings
  7.8.4 OncoHealth Cervical Cancer Diagnostic Revenue in Global Market (2017-2022)
  7.8.5 OncoHealth Key News
7.9 Arbor Vita
  7.9.1 Arbor Vita Corporate Summary
  7.9.2 Arbor Vita Business Overview
  7.9.3 Arbor Vita Cervical Cancer Diagnostic Major Product Offerings
  7.9.4 Arbor Vita Cervical Cancer Diagnostic Revenue in Global Market (2017-2022)
  7.9.5 Arbor Vita Key News
7.10 Zilico
  7.10.1 Zilico Corporate Summary
  7.10.2 Zilico Business Overview
  7.10.3 Zilico Cervical Cancer Diagnostic Major Product Offerings
  7.10.4 Zilico Cervical Cancer Diagnostic Revenue in Global Market (2017-2022)
  7.10.5 Zilico Key News
7.11 Beckman Coulter
  7.11.1 Beckman Coulter Corporate Summary
  7.11.2 Beckman Coulter Business Overview
  7.11.3 Beckman Coulter Cervical Cancer Diagnostic Major Product Offerings
  7.11.4 Beckman Coulter Cervical Cancer Diagnostic Revenue in Global Market (2017-2022)
  7.11.5 Beckman Coulter Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cervical Cancer Diagnostic Market Opportunities & Trends in Global Market
Table 2. Cervical Cancer Diagnostic Market Drivers in Global Market
Table 3. Cervical Cancer Diagnostic Market Restraints in Global Market
Table 4. Key Players of Cervical Cancer Diagnostic in Global Market
Table 5. Top Cervical Cancer Diagnostic Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cervical Cancer Diagnostic Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cervical Cancer Diagnostic Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cervical Cancer Diagnostic Product Type
Table 9. List of Global Tier 1 Cervical Cancer Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cervical Cancer Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cervical Cancer Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cervical Cancer Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cervical Cancer Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cervical Cancer Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cervical Cancer Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cervical Cancer Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cervical Cancer Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cervical Cancer Diagnostic Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cervical Cancer Diagnostic Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cervical Cancer Diagnostic Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cervical Cancer Diagnostic Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cervical Cancer Diagnostic Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cervical Cancer Diagnostic Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cervical Cancer Diagnostic Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cervical Cancer Diagnostic Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cervical Cancer Diagnostic Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cervical Cancer Diagnostic Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cervical Cancer Diagnostic Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cervical Cancer Diagnostic Revenue, (US$, Mn), 2023-2028
Table 30. Cooper Surgical Corporate Summary
Table 31. Cooper Surgical Cervical Cancer Diagnostic Product Offerings
Table 32. Cooper Surgical Cervical Cancer Diagnostic Revenue (US$, Mn), (2017-2022)
Table 33. Becton Dickinson Corporate Summary
Table 34. Becton Dickinson Cervical Cancer Diagnostic Product Offerings
Table 35. Becton Dickinson Cervical Cancer Diagnostic Revenue (US$, Mn), (2017-2022)
Table 36. Hologic Corporate Summary
Table 37. Hologic Cervical Cancer Diagnostic Product Offerings
Table 38. Hologic Cervical Cancer Diagnostic Revenue (US$, Mn), (2017-2022)
Table 39. Quest Diagnostics Corporate Summary
Table 40. Quest Diagnostics Cervical Cancer Diagnostic Product Offerings
Table 41. Quest Diagnostics Cervical Cancer Diagnostic Revenue (US$, Mn), (2017-2022)
Table 42. QIAGEN Corporate Summary
Table 43. QIAGEN Cervical Cancer Diagnostic Product Offerings
Table 44. QIAGEN Cervical Cancer Diagnostic Revenue (US$, Mn), (2017-2022)
Table 45. Guided Therapeutics Corporate Summary
Table 46. Guided Therapeutics Cervical Cancer Diagnostic Product Offerings
Table 47. Guided Therapeutics Cervical Cancer Diagnostic Revenue (US$, Mn), (2017-2022)
Table 48. Siemens Corporate Summary
Table 49. Siemens Cervical Cancer Diagnostic Product Offerings
Table 50. Siemens Cervical Cancer Diagnostic Revenue (US$, Mn), (2017-2022)
Table 51. OncoHealth Corporate Summary
Table 52. OncoHealth Cervical Cancer Diagnostic Product Offerings
Table 53. OncoHealth Cervical Cancer Diagnostic Revenue (US$, Mn), (2017-2022)
Table 54. Arbor Vita Corporate Summary
Table 55. Arbor Vita Cervical Cancer Diagnostic Product Offerings
Table 56. Arbor Vita Cervical Cancer Diagnostic Revenue (US$, Mn), (2017-2022)
Table 57. Zilico Corporate Summary
Table 58. Zilico Cervical Cancer Diagnostic Product Offerings
Table 59. Zilico Cervical Cancer Diagnostic Revenue (US$, Mn), (2017-2022)
Table 60. Beckman Coulter Corporate Summary
Table 61. Beckman Coulter Cervical Cancer Diagnostic Product Offerings
Table 62. Beckman Coulter Cervical Cancer Diagnostic Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Cervical Cancer Diagnostic Segment by Type in 2021
Figure 2. Cervical Cancer Diagnostic Segment by Application in 2021
Figure 3. Global Cervical Cancer Diagnostic Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cervical Cancer Diagnostic Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cervical Cancer Diagnostic Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cervical Cancer Diagnostic Revenue in 2021
Figure 8. By Type - Global Cervical Cancer Diagnostic Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cervical Cancer Diagnostic Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cervical Cancer Diagnostic Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cervical Cancer Diagnostic Revenue Market Share, 2017-2028
Figure 12. US Cervical Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cervical Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cervical Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cervical Cancer Diagnostic Revenue Market Share, 2017-2028
Figure 16. Germany Cervical Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 17. France Cervical Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cervical Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cervical Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cervical Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cervical Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cervical Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cervical Cancer Diagnostic Revenue Market Share, 2017-2028
Figure 24. China Cervical Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cervical Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cervical Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cervical Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 28. India Cervical Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cervical Cancer Diagnostic Revenue Market Share, 2017-2028
Figure 30. Brazil Cervical Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cervical Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cervical Cancer Diagnostic Revenue Market Share, 2017-2028
Figure 33. Turkey Cervical Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cervical Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cervical Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cervical Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 37. Cooper Surgical Cervical Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Becton Dickinson Cervical Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Hologic Cervical Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Quest Diagnostics Cervical Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. QIAGEN Cervical Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Guided Therapeutics Cervical Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Siemens Cervical Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. OncoHealth Cervical Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Arbor Vita Cervical Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Zilico Cervical Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Beckman Coulter Cervical Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)